Trial Outcomes & Findings for A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children (NCT NCT05204082)

NCT ID: NCT05204082

Last Updated: 2024-05-23

Results Overview

Percentage of participants to have an IV access within the first attempt when using the SU-VEID Device in comparison to the conventional procedure

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

169 participants

Primary outcome timeframe

Baseline

Results posted on

2024-05-23

Participant Flow

Participant milestones

Participant milestones
Measure
Standard IV Insertion
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion
SU-VEID Assisted IV Insertion
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device Single Use Vein Entry Indicator Device: Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.
Overall Study
STARTED
84
85
Overall Study
COMPLETED
84
85
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard IV Insertion
n=84 Participants
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion
SU-VEID Assisted IV Insertion
n=85 Participants
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device Single Use Vein Entry Indicator Device: Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.
Total
n=169 Participants
Total of all reporting groups
Age, Continuous
5.31 years
STANDARD_DEVIATION 3.99 • n=84 Participants
5.35 years
STANDARD_DEVIATION 4.19 • n=85 Participants
5.33 years
STANDARD_DEVIATION 4.086 • n=169 Participants
Sex: Female, Male
Female
36 Participants
n=84 Participants
36 Participants
n=85 Participants
72 Participants
n=169 Participants
Sex: Female, Male
Male
48 Participants
n=84 Participants
49 Participants
n=85 Participants
97 Participants
n=169 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
84 participants
n=84 Participants
85 participants
n=85 Participants
169 participants
n=169 Participants

PRIMARY outcome

Timeframe: Baseline

Percentage of participants to have an IV access within the first attempt when using the SU-VEID Device in comparison to the conventional procedure

Outcome measures

Outcome measures
Measure
Standard IV Insertion
n=84 Participants
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion
SU-VEID Assisted IV Insertion
n=85 Participants
Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device Single Use Vein Entry Indicator Device: Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.
Percentage of Participants With IV Access at First Attempt
70.2 percentage of participants
67.1 percentage of participants

Adverse Events

Standard IV Insertion

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SU-VEID Assisted IV Insertion

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Michael E. Nemergut, M.D., Ph.D.

Mayo Clinic

Phone: 507-255-7976

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place